|
Immunotherapy in Hispanic patients with advanced non-small cell lung cancer: A real-world data. |
|
|
Consulting or Advisory Role - Abbott; MSD |
Speakers' Bureau - Abbott; Bayer; Bristol-Myers Squibb; MSD; Pfizer |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Roche |
|
|
Travel, Accommodations, Expenses - Roche |
|
|
No Relationships to Disclose |
|
Andres Felipe Cardona Zorrilla |
Honoraria - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Celldex; Merck Sharp & Dohme; Roche |
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Foundation for Clinical and Applied Cancer Research (FICMAC); Foundation Medicine; Merck Sharp & Dohme; Novartis; Roche |
Speakers' Bureau - Bristol-Myers Squibb; Foundation for Clinical and Applied Cancer Research (FICMAC); Foundation Medicine; Merck Sharp & Dohme; Novartis; Roche |
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Foundation Medicine; Merck Sharp & Dohme; Roche |
|
|
No Relationships to Disclose |
|
|
|
Leadership - Hemato-Oncologos Asociados |
Stock and Other Ownership Interests - Pfizer (I) |
Honoraria - Amgen; Janssen-Cilag; Roche |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Lilly; Roche |
Research Funding - Amgen (Inst); Pfizer (Inst) |
|
|
No Relationships to Disclose |
|
|
Speakers' Bureau - AstraZeneca/Merck; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche |
Travel, Accommodations, Expenses - AstraZeneca/Merck; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca/Merck |
Travel, Accommodations, Expenses - AstraZeneca/Merck; Janssen; Roche |
|
|
No Relationships to Disclose |
|
|
Employment - Amgen; Astellas Oncology; AstraZeneca/Merck; Bayer; Bristol-Myers Squibb; Janssen; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Tecnofarma |
Honoraria - Amgen; Astellas Oncology; AstraZeneca/Merck; Bayer; Bristol-Myers Squibb; Grupo Biotoscana; Janssen; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Tecnofarma |
Consulting or Advisory Role - Amgen; Astellas Oncology; AstraZeneca/Merck; Bayer; Bristol-Myers Squibb; Janssen; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Tecnofarma |
Research Funding - MSD; Novartis |
Expert Testimony - Astellas Oncology; Janssen; MSD |
Travel, Accommodations, Expenses - Astellas Oncology; AstraZeneca/Merck; Grupo Biotoscana; Janssen |
|
|
Honoraria - AstraZeneca/Merck; Bristol-Myers Squibb; Merck Sharp & Dohme |
Consulting or Advisory Role - AstraZeneca/Merck; Bristol-Myers Squibb; Merck Sharp & Dohme |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb |
Speakers' Bureau - Astellas Oncology; Merck Sharp & Dohme |
Travel, Accommodations, Expenses - Tecnofarma |